MARAVAI LIFESCIENCES HOLDINGS, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2020 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Maravai Lifesciences Holdings, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2020 to Q1 2024.
  • Maravai Lifesciences Holdings, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$560K, a 97.1% increase year-over-year.
  • Maravai Lifesciences Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$61.1M, a 67.4% increase from 2022.
  • Maravai Lifesciences Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$187M, a 17.9% decline from 2021.
  • Maravai Lifesciences Holdings, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$159M, a 399% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$560K +$18.6M +97.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 -$19.2M +$21.3M +52.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 -$40.5M -$16.5M -68.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q1 2021 -$24.1M -$38.4M -268% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 $14.3M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.